Healy James

Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: $0

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
BIOA	BioAge Labs, Inc.	$0	$0	$0	—	Jun 10
RAPP	Rapport Therapeutics, Inc.	$0	$0	$0	—	Jun 10
SPTX	Seaport Therapeutics, Inc.	$0	$0	$0	2.7M	May 4
YMAB	Y-mAbs Therapeutics, Inc.	$0	$0	$0	0	Sep 16, 2025
NTRA	Natera, Inc.	$0	$0	$0	46,260	Apr 25, 2025

BIOA

BioAge Labs, Inc.

Bought

Sold

Held

—

RAPP

Rapport Therapeutics, Inc.

Bought

Sold

Held

—

SPTX

Seaport Therapeutics, Inc.

Bought

Sold

Held

2.7M

YMAB

Y-mAbs Therapeutics, Inc.

Bought

Sold

Filing record

How quickly this filer reports. Section 16 allows two business days from the transaction.

All 6 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Trade history

The 22 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Jun 10	RAPP	Rapport Therapeutics, Inc.	AGRANT◆	15,200	—	—	—	Open the original filing on SEC.gov
Jun 10	BIOA	BioAge Labs, Inc.	AGRANT◆	22,000	—	—	—